Yufan Chen1, Lianyong Li2, Enbo Wang1, Lijun Zhang1, Qun Zhao1. 1. Department of Pediatric Orthopedics, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang City, 110004, Liaoning Province, PR China. 2. Department of Pediatric Orthopedics, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang City, 110004, Liaoning Province, PR China. loyo_ldy@163.com.
Abstract
INTRODUCTION: Developmental dysplasia of the hip (DDH) is a major cause of disability in children, and the genetic mechanism of this disease remains unclear. In our previous study, we found that pregnancy-associated plasma protein-A2 (PAPP-A2) was associated with DDH significantly. OBJECTIVES: The aim of this study was to investigate the insulin-like growth factor (IGF) expression and collagen synthesis as well as cartilage proliferation-related proteins in the case of abnormal expression of Pappa2 in mice to research the relationship between PAPP-A2 and the pathological changes of DDH. METHODS: In vivo animal experiments, the mice were directly injected with 50 µl of Cas9/PAPP-A2 sgRNA lentiviruses around the hip to downregulate the Pappa2 gene expression and injected with control lentiviruses on the other side, then to observe the expression and localization of related proteins. And in an in vitro experiment, mice fibroblasts and primary chondrocytes were cultured with insulin-like growth factor binding protein-5 (IGFBP-5) protein, PAPP-A2 protein and Cas9/PAPP-A2 sgRNA lentiviruses to detect of related proteins and mRNA expression. RESULTS: Cartilage proliferation-related proteins demonstrated a significant decrease in the PAPP-A2 knockdown hips acetabulum and femoral head cartilage, meanwhile the IGF expression was also downregulated in the soft tissue around the acetabulum compared with the control hips. Furthermore, the role PAPP-A2 played in chondrocytes and fibroblasts was the same as in the in vivo experiments, downregulation of PAPP-A2 expression or upregulation of IGFBP-5 expression can reduce collagen synthesis and cartilage proliferation. CONCLUSIONS: PAPP-A2 may be involved in the development of the mouse hip joint by interfering the fibrous and cartilaginous metabolism via IGF pathway-associated proteins pathway.
INTRODUCTION:Developmental dysplasia of the hip (DDH) is a major cause of disability in children, and the genetic mechanism of this disease remains unclear. In our previous study, we found that pregnancy-associated plasma protein-A2 (PAPP-A2) was associated with DDH significantly. OBJECTIVES: The aim of this study was to investigate the insulin-like growth factor (IGF) expression and collagen synthesis as well as cartilage proliferation-related proteins in the case of abnormal expression of Pappa2 in mice to research the relationship between PAPP-A2 and the pathological changes of DDH. METHODS: In vivo animal experiments, the mice were directly injected with 50 µl of Cas9/PAPP-A2 sgRNA lentiviruses around the hip to downregulate the Pappa2 gene expression and injected with control lentiviruses on the other side, then to observe the expression and localization of related proteins. And in an in vitro experiment, mice fibroblasts and primary chondrocytes were cultured with insulin-like growth factor binding protein-5 (IGFBP-5) protein, PAPP-A2 protein and Cas9/PAPP-A2 sgRNA lentiviruses to detect of related proteins and mRNA expression. RESULTS:Cartilage proliferation-related proteins demonstrated a significant decrease in the PAPP-A2 knockdown hips acetabulum and femoral head cartilage, meanwhile the IGF expression was also downregulated in the soft tissue around the acetabulum compared with the control hips. Furthermore, the role PAPP-A2 played in chondrocytes and fibroblasts was the same as in the in vivo experiments, downregulation of PAPP-A2 expression or upregulation of IGFBP-5 expression can reduce collagen synthesis and cartilage proliferation. CONCLUSIONS:PAPP-A2 may be involved in the development of the mousehip joint by interfering the fibrous and cartilaginous metabolism via IGF pathway-associated proteins pathway.
Entities:
Keywords:
Developmental dysplasia of the hip; Insulin-like growth factor; Insulin-like growth factor binding protein-5; Pregnancy-associated plasma protein-A2
Authors: M Warnken; U Reitzenstein; A Sommer; M Fuhrmann; P Mayer; H Enzmann; U R Juergens; K Racké Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2010-10-06 Impact factor: 3.000
Authors: K Rouault; V Scotet; S Autret; F Gaucher; F Dubrana; D Tanguy; C Yaacoub El Rassi; B Fenoll; C Férec Journal: Osteoarthritis Cartilage Date: 2009-03-24 Impact factor: 6.576
Authors: Andrew Dauber; María T Muñoz-Calvo; Vicente Barrios; Horacio M Domené; Soren Kloverpris; Clara Serra-Juhé; Vardhini Desikan; Jesús Pozo; Radhika Muzumdar; Gabriel Á Martos-Moreno; Federico Hawkins; Héctor G Jasper; Cheryl A Conover; Jan Frystyk; Shoshana Yakar; Vivian Hwa; Julie A Chowen; Claus Oxvig; Ron G Rosenfeld; Luis A Pérez-Jurado; Jesús Argente Journal: EMBO Mol Med Date: 2016-04-01 Impact factor: 12.137
Authors: Ashlee E Williams; James Watt; Larry W Robertson; Gopi Gadupudi; Michele L Osborn; Michael J Soares; Khursheed Iqbal; Kim B Pedersen; Kartik Shankar; Shana Littleton; Cole Maimone; Nazmin A Eti; Larry J Suva; Martin J J Ronis Journal: Toxicol Sci Date: 2020-05-01 Impact factor: 4.849
Authors: Daniela Ohde; Michael Walz; Christina Walz; Antonia Noce; Julia Brenmoehl; Martina Langhammer; Andreas Hoeflich Journal: Cells Date: 2020-09-26 Impact factor: 6.600